RXST.US Rxsight Inc

Healthcare Health Care Equipment & Supplies USA Stocks
5.30 USD
Close of Nov 17, 2026
4.11 13.22
Market cap
USD 222M
P/E
-
P/B
0.88x
ROE
-23.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is RXST.US undervalued?

Graham number

The Graham number of Rxsight Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Rxsight Inc fundamental analysis

No fundamental analysis for Rxsight Inc yet.

Rxsight Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Rxsight Inc

RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that chan…

Full company profile